FDA clears 2nd COVID booster for Americans ages 50 and up


The U.S. Food and Drug Administration on Tuesday authorized a second booster dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines for use in adults ages 50 and older, NBC News reports.
Individuals are eligible for a second booster dose at least four months after receiving their first booster, the FDA said, per NBC News. It does not matter which brand of vaccine a person initially received.
Centers for Disease Control and Prevention Director Rochelle Walensky is expected to sign off on the decision shortly. The FDA had already authorized a fourth shot for immunocompromised Americans, per NBC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The CDC will likely say people older than 50 can get a second booster, rather than explicitly recommending they do so, The Washington Post reports, "a reflection of the ongoing debate about the benefits of additional doses and uncertainties about the future of the pandemic." The federal agency will also likely "highlight vulnerable populations" within the designated age group.
Even with the FDA and (eventually) CDC's decision, health officials "likely face an uphill battle in another vaccine campaign," notes The Wall Street Journal. Approximately two-thirds of adults over age 65 have received a booster, and less than half of the adult population has.
The extra shots will be available through "physician offices, retail pharmacies, nursing homes and other vaccination sites," per the Journal. A fourth shot is expected to be authorized for the broader population this fall.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
How global conflicts are reshaping flight paths
Under the Radar Airlines are having to take longer and convoluted routes to avoid conflict zones
-
Zohran Mamdani: the young progressive likely to be New York City's next mayor
In The Spotlight The policies and experience that led to his meteoric rise
-
The best film reboots of all time
The Week Recommends Creativity and imagination are often required to breathe fresh life into old material
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths